Michelle Quinn, NP
Nurse Practitioner · Palo Alto, CANPI 1952332231
Payments from drug & device makers
Across 66 payments — averaging $23.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$281
- AbbVie$217
- Pfizer$174
- Regeneron Healthcare Solutions, Inc.$173
- Incyte Corporation$151
- VYNE Pharmaceuticals Inc.$71
- plus $506 from 13 others
What the payments were for
- Food & beverage$1,571100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 12 | $281 |
| AbbVie | 8 | $217 |
| Pfizer | 8 | $174 |
| Regeneron Healthcare Solutions, Inc. | 7 | $173 |
| Incyte Corporation | 6 | $151 |
| VYNE Pharmaceuticals Inc. | 2 | $71 |
| LEO Pharma Inc. | 3 | $70 |
| Galderma Laboratories, L.p. | 4 | $63 |
| Organon | 2 | $62 |
| Biofrontera Inc. | 2 | $59 |
| Johnson & Johnson | 3 | $52 |
| Strata Skin Sciences, Inc. | 2 | $46 |
| Revance Therapeutics, Inc. | 1 | $32 |
| Arcutis Biotherapeutics, Inc. | 1 | $29 |
| Novartis | 1 | $25 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $25 |
| Lilly USA, LLC | 1 | $17 |
| Verrica Pharmaceuticals Inc. | 1 | $15 |
| Mayne Pharma Commercial LLC | 1 | $11 |
How this compares
$1,571 in reported general payments places this provider in the 85th percentile of 6,779 nurse practitioner providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 119 | $1,850 |
| Ciclopirox | 34 | $1,309 |
| Metronidazole | 18 | $933 |
| Triamcinolone Acetonide | 55 | $522 |
| Clindamycin Phosphate | 12 | $388 |
| Doxycycline Hyclate | 14 | $321 |
| Mometasone Furoate | 15 | $266 |
| Nystatin | 19 | $242 |
| Mupirocin | 21 | $152 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Palo Alto
- Jong Mi LeePalo Alto$174K
- Carol BarchPalo Alto$76K
- Holly BernalPalo Alto$63K
- Lindsay MartinPalo Alto$37K
- Janice LuPalo Alto$27K
- Rhonda HewittStanford$917K
- Linda TrinhIrvine$899K
- Denise SinagaNorthridge$728K
- Debbie TaySanta Monica$642K
- Joe GorelickCampbell$638K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.